AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Infliximab in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Remicade** Powder for concentrate for solution for infusion | A6-0490 | J & J Company West Africa Limited | active | 22 Jun 2028 |
Infliximab — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Infliximab, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Infliximab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.